RxDoctor Payments Data

Sergio Mather

Endocrinology, Diabetes & Metabolism · Fort Myers, FLNPI 1013915024

Payments from drug & device makers

$3,609in general payments, 2019–2025

Across 234 payments — averaging $15.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sanofi-aventis U.S. LLC$549
  • Novo Nordisk$531
  • AstraZeneca$520
  • Lilly USA, LLC$249
  • Merck$229
  • Amgen$211
  • plus $1K from 26 others

What the payments were for

  • Food & beverage$3,58199%
  • Education$281%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,609 in reported general payments places this provider in the 45th percentile of 586 endocrinology, diabetes & metabolism providers in Florida.

See all endocrinology, diabetes & metabolism providers in Florida

Other endocrinology, diabetes & metabolism in Fort Myers

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →